Lunai Bioworks (LNAI) Cost of Revenue (2013 - 2022)

Lunai Bioworks' Cost of Revenue history runs 7 years deep, the most recent figure standing at $4.0 million for Q1 2022.

• In Q1 2022, Cost of Revenue rose 32.11% year-over-year to $4.0 million; the TTM figure through Mar 2026 stood at $17.9 million (changed N/A YoY), while the FY2016 annual figure was $5275.0, down 92.0% from the prior year.
• Cost of Revenue was $4.0 million for Q1 2022 at Lunai Bioworks, down from $6.3 million in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $7.5 million in Q3 2021 to a low of $2.9 million in Q3 2020.
• Historically, Cost of Revenue has averaged $4.5 million across 3 years, with a median of $3.7 million in 2020.
• The sharpest annual moves came in 2021 and 2022: Cost of Revenue jumped 162.52% in 2021, then jumped 32.11% in 2022.
• A 3-year view of Cost of Revenue shows it stood at $3.3 million in 2020, then surged by 91.54% to $6.3 million in 2021, then tumbled by 36.27% to $4.0 million in 2022.
• The last three Cost of Revenue figures came in at $4.0 million (Q1 2022), $6.3 million (Q4 2021), and $7.5 million (Q3 2021), per Business Quant data.